
Peptides
Peptides are short chains of amino acids linked by peptide bonds, serving as important biological molecules that play key roles in cellular processes. They function as hormones, neurotransmitters, and signaling molecules, and are widely used in therapeutic and diagnostic applications. Peptides are also crucial in research for studying protein interactions, enzyme activities, and cell signaling pathways. At CymitQuimica, we provide a diverse selection of high-quality peptides to support your research and development needs in biotechnology and pharmaceuticals.
Subcategories of "Peptides"
Products of "Peptides"
Sort by
ACTA1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ACTA1 antibody, catalog no. 70R-10210Purity:Min. 95%DAP3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of DAP3 antibody, catalog no. 70R-10345Purity:Min. 95%BTNL8 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of BTNL8 antibody, catalog no. 70R-8838Purity:Min. 95%Orexin B, human
CAS:Orexin B, human agonizes Orexin receptors (OX1 Ki=420 nM, OX2 Ki=36 nM), promotes feeding in rats, and is a neuropeptide.Formula:C123H212N44O35SPurity:98%Color and Shape:SolidMolecular weight:2899.34Cortistatin-14
CAS:Cortistatin-14, a neuropeptide structurally similar to growth inhibitor-14, is used to study sepsis-induced cognitive impairment.Formula:C81H114N20O18S2Purity:98.06%Color and Shape:SolidMolecular weight:1720.03MLXIPL Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of MLXIPL antibody, catalog no. 20R-1229Purity:Min. 95%Ac-CDGPTEIYKLTRKEAQE-OH
Peptide Ac-CDGPTEIYKLTRKEAQE-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Ac-CDGPTEIYKLTRKEAQE-OH include the following: Wnt ligands from the embryonic surface ectoderm regulate 'bimetallic strip'optic cup morphogenesis in mouse AC Carpenter, AN Smith, H Wagner - , 2015 - journals.biologists.comhttps://journals.biologists.com/dev/article-abstract/142/5/972/47238Histatin 5
This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.H-TEIALSGK^-OH
Peptide H-TEIALSGK^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-TEIALSGK^-OH include the following: Arthur Viode1, Clemence Fournier2, 3, Agnacašs Camuzat2, 4, Franaca§ois Fenaille1, NeuroCEB Brain Bank, Morwena Latouche2, 4, Fanny Elahi5, Isabelle Le Ber2, 3, 6 LP Sugrue - Genetics of Neurodegenerative Diseases, 2021 - books.google.comhttps://books.google.com/books?hl=en&lr=&id=O8JSEAAAQBAJ&oi=fnd&pg=PA75&dq=(%22TEIALSGK%22+OR+%22H-TEIALSGK%5E-OH%22+OR+%22H-TEIALSGK-OH%22+OR+%22TEIALSGK%5E%22)+AND+peptide&ots=ZjyONTXHv8&sig=1uHMdtVgBbs2rxSax15B0NswEo0 New antibody-free mass spectrometry-based quantification reveals that C9ORF72 long protein isoform is reduced in the frontal cortex of hexanucleotide-repeat A Viode, C Fournier, A Camuzat, F Fenaille - Frontiers in , 2018 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fnins.2018.00589/fullH-RLL^GTEFQV-OH
Peptide H-RLL^GTEFQV-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-RLL^GTEFQV-OH include the following: MEK inhibition enhances presentation of targetable MHC-I tumor antigens in mutant melanomas LE Stopfer , NJ Rettko, O Leddy - Proceedings of the , 2022 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.2208900119 Absolute quantification of tumor antigens using embedded MHC-I isotopologue calibrants LE Stopfer , AS Gajadhar, B Patel - Proceedings of the , 2021 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.2111173118 SLC45A2: a melanoma antigen with high tumor selectivity and reduced potential for autoimmune toxicity J Park, AH Talukder, SA Lim, K Kim, K Pan - Cancer immunology , 2017 - AACRhttps://aacrjournals.org/cancerimmunolres/article-abstract/5/8/618/468798Ac-HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2
Peptide Ac-HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Ac-HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2 include the following: Characterization of an insulinotropic peptide from skin secretions of Odorrana andersonii W Shang, X Yang, X Ju, Y Xie, Y Zhang - Journal of Peptide , 2017 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/psc.3017H-Myr-GSNK^SK^PK-NH2
Peptide H-Myr-GSNK^SK^PK-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-Myr-GSNK^SK^PK-NH2 include the following: Inhibition of N-myristoyltransferase activity promotes androgen receptor degradation in prostate cancer OA Alsaidan , E Onobun , C Ye, L Lou , Z Beharry - The ..., 2024 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/pros.24645 Extracellular vesicles: The next generation of biomarkers and treatment for central nervous system diseases G Zanirati, PG Dos Santos, AM Alcará, F Bruzzo- International Journal of ..., 2024 - mdpi.comhttps://www.mdpi.com/1422-0067/25/13/7371 Engineering extracellular vesicles to deliver CRISPR ribonucleoprotein for gene editing JA Whitley , H Cai - Journal of Extracellular Vesicles, 2023 - Wiley Online Libraryhttps://isevjournals.onlinelibrary.wiley.com/doi/abs/10.1002/jev2.12343 Encapsulating Cas9 into extracellular vesicles by protein myristoylation JA Whitley , S Kim, L Lou , C Ye- Journal of ..., 2022 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/jev2.12196 BFSP1 C-terminal domains released by post-translational processing events can alter significantly the calcium regulation of AQP0 water permeability A Tapodi , DM Clemens , A Uwineza , M Jarrin- Experimental eye ..., 2019 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0014483518307395H-RLRPGGKKKY-OH
Peptide H-RLRPGGKKKY-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-RLRPGGKKKY-OH include the following: Priming immunization with DNA augments immunogenicity of recombinant adenoviral vectors for both HIV-1 specific antibody and T-cell responses RA Koup, M Roederer , L Lamoreaux, J Fischer - PloS one, 2010 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0009015 Widespread impact of HLA restriction on immune control and escape pathways of HIV-1 JM Carlson , J Listgarten , N Pfeifer , V Tan - Journal of , 2012 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.06728-11 Multilayered HIV-1 gag-specific T-cell responses contribute to slow progression in HLA-A* 30-B* 13-C* 06-positive patients H Zhang, X Han, B Zhao, M An, Z Wang, F Jiang, J Xu - Aids, 2015 - journals.lww.comhttps://journals.lww.com/aidsonline/fulltext/2015/06010/multilayered_hiv_1_gag_specific_t_cell_responses.4.aspxBis-dPEG®7-Acid
CAS:Bis-dPEG®7-Acid is a PEG polymer categorised as homobifunctional PEG (X-PEG X). Used as a linker, bis-dPEG®7-Acid is used to attached PEG to proteins, peptides, oligonucleotides, nanoparticles and small molecules via pegylation, a bioconjugation technique.Formula:C22H39NO12Purity:Min. 95%Molecular weight:509.54 g/molPPP2R3A Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PPP2R3A antibody, catalog no. 70R-2338For-Nle-Leu-Phe-OH
CAS:Nle-Leu-Phe-OH is a potent colony-stimulating factor that binds to the receptor on the surface of cells and stimulates the production of white blood cells. Nle-Leu-Phe-OH has been shown to induce actin filament formation, which is necessary for cell movement. It also induces cytosolic calcium release and enhances protein synthesis. Nle-Leu-Phe-OH also binds to phosphatase and inhibits its activity, which may be due to a conformational change in the enzyme. This process is necessary for the synthesis of DNA and other proteins from amino acids. Nle-Leu-Phe-OH also causes an increase in the uptake of Ca2+ ions by cells.Formula:C22H33N3O5Purity:Min. 95%Molecular weight:419.51 g/molBim BH3, Peptide IV
CAS:This Bim peptide belongs to the pro-apoptotic group of the Bcl-2 family of proteins.Formula:C145H222N44O41SPurity:98%Color and Shape:SolidMolecular weight:3269.65VPS28 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of VPS28 antibody, catalog no. 70R-2489Purity:Min. 95%B3GAT3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of B3GAT3 antibody, catalog no. 70R-6768Purity:Min. 95%TLQP-62, Rat
Custom research peptide; min purity 95%. For different specs please use the Peptide Quote ToolMolecular weight:7,401.13 g/molMyr-RIIDLLWRVRRPQKPKFVTVWVR-OH
Peptide Myr-RIIDLLWRVRRPQKPKFVTVWVR-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Myr-RIIDLLWRVRRPQKPKFVTVWVR-OH include the following: Broad-spectrum hybrid antimicrobial peptides derived from PMAP-23 with potential LPS binding ability Y Lyu, M Tan, M Xue, W Hou, C Yang, A Shan - Biochemical , 2023 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006295223000916 Possible role of a PXXP central hinge in the antibacterial activity and membrane interaction of PMAP-23, a member of cathelicidin family ST Yang, JH Jeon, Y Kim , SY Shin, KS Hahm - Biochemistry, 2006 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/bi051524k Lipid-soluble hydroquinone modifications induced on membranes SS Funari, V Rebbin, L Marzorati, C Di Vitta - Biophysical Journal, 2011 - cell.comhttps://www.cell.com/biophysj/pdf/S0006-3495(10)05111-8.pdf Porcine myeloid antimicrobial peptides: a review of the activity and latest advances S Shi, T Shen, Y Liu, L Chen, C Wang - Frontiers in Veterinary , 2021 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fvets.2021.664139/full Probing the role of Proline in the antimicrobial activity and lipopolysaccharide binding of indolicidin S Bera , A Ghosh , S Sharma, T Debnath, B Giri - Journal of colloid and , 2015 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0021979715004014 C-terminal amidation of PMAP-23: translocation to the inner membrane of Gram-negative bacteria JY Kim, SC Park, MY Yoon, KS Hahm, Y Park - Amino acids, 2011 - Springerhttps://link.springer.com/article/10.1007/s00726-010-0632-1 Inclusion of menaquinone in lipid membranes decreases susceptibility to antimicrobial peptides J Nepper - Biophysical Journal, 2011 - cell.comhttps://www.cell.com/biophysj/pdf/S0006-3495(10)05107-6.pdf Lipid Bilayers of Ester-Modified Lipids DY Villanueva, JB Lim , JB Klauda - Biophysical Journal, 2011 - cell.comhttps://www.cell.com/biophysj/pdf/S0006-3495(10)05110-6.pdf Regulation of Antimicrobial Peptide Activity through Lipid Chain Order DA Ramirez , DE Otzen, C Leidy - Biophysical Journal, 2011 - cell.comhttps://www.cell.com/biophysj/pdf/S0006-3495(10)05109-X.pdf In Vivo 2H-NMR Study of the Action of Antibacterial Agents on Escherichia Coli Membranes C Tardy-Laporte, AA Arnold, I Marcotte - Biophysical Journal, 2011 - cell.comhttps://www.cell.com/biophysj/pdf/S0006-3495(10)05108-8.pdfPILRB Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PILRB antibody, catalog no. 70R-7227Purity:Min. 95%RFTN2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of RFTN2 antibody, catalog no. 70R-4543Purity:Min. 95%ZNF668 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF668 antibody, catalog no. 70R-7997Purity:Min. 95%N-(tert-Butoxycarbonyl)-cis-4-hydroxy-D-proline Methyl Ester
CAS:Formula:C11H19NO5Purity:>97.0%(GC)Color and Shape:White to Almost white powder to crystalMolecular weight:245.28H-AVTLSLDGGDTAIR-OH
Peptide H-AVTLSLDGGDTAIR-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-AVTLSLDGGDTAIR-OH include the following: Liquid chromatography-tandem mass spectrometry approach for quantification of mucins from sputum using 13C, 15N-labeled peptides as internal standards C Lindberg, M van Geest, H Lindberg - Analytical Biochemistry, 2013 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0003269712005520H-LPPVVAKEI-OH
Peptide H-LPPVVAKEI-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-LPPVVAKEI-OH include the following: Novel HIV-1 clade B candidate vaccines designed for HLA-B*5101+ patients protected mice against chimaeric ecotropic HIV-1 challenge Y Roshorm , JP Hong, N Kobayashi - European journal of , 2009 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.200939309 Evolution of human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitopes: fitness-balanced escape Y Liu, J McNevin, H Zhao, DM Tebit, RM Troyer - Journal of , 2007 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/JVI.01277-07 An in silico Approach for Epitope Based Vaccine Design Against Ebola virus S Radhakrishnan, ME Sobhia - Archives of Microbiology & , 2021 - fortuneonline.orghttps://fortuneonline.org/articles/an-in-silico-approach-for-epitope-based-vaccine-design-against-ebola-virus.html Mining the Mycobacterium tuberculosis proteome for identification of potential T-cell epitope based vaccine candidates R Madan , K Pandit , L Bhati, H Kumar, N Kumari - Microbial , 2021 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0882401021002680 Principles and aspects of molecular docking: A bird's eye view R Madan , K Pandit , H Kumar, N Kumari - Hans Shodh , 2020 - hansshodhsudha.comhttps://www.hansshodhsudha.com/first-second-issues/New%20Hansraj%20College%20Book-1-110-121.pdf Longitudinal analysis of an HLA-B* 51-restricted epitope in integrase reveals immune escape in early HIV-1 infection N Yager, N Robinson, H Brown, P Flanagan , J Frater - AIDS, 2013 - journals.lww.comhttps://journals.lww.com/aidsonline/fulltext/2013/01280/longitudinal_analysis_of_an_hla_b_51_restricted.2.aspx Nonstandard Peptide Binding Revealed by M Takiguchi, DI Stuart , EY Jones , K Maenaka - J , 2000 - researchgate.nethttps://www.researchgate.net/profile/David_Stuart4/publication/12346091_Nonstandard_Peptide_Binding_Revealed_by_Crystal_Structures_of_HLA-B5101_Complexed_with_HIV_Immunodominant_Epitopes/links/56d4296608ae2ea08cf8db44/Nonstandard-Peptide-Binding-Revealed-by-Crystal-Structures-of-HLA-B5101-Complexed-with-HIV-Immunodominant-Epitopes.pdf Molecular dynamics simulations provide molecular insights into the role of HLA-B51 in Behaca§et's disease pathogenesis M Gur , M Golcuk , A Gul, B Erman - Chemical Biology & Drug , 2020 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/cbdd.13658 Analysis of the DosR regulon genes to select cytotoxic T lymphocyte epitope specific vaccine candidates using a reverse vaccinology approach K Pandey , M Sharma , I Saarav, S Singh , P Dutta - International Journal of , 2016 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S2212553115001594 Nonstandard peptide binding revealed by crystal structures of HLA-B* 5101 complexed with HIV immunodominant epitopes K Maenaka, T Maenaka, H Tomiyama - The Journal of , 2000 - journals.aai.orghttps://journals.aai.org/jimmunol/article/165/6/3260/69809 acaâacaË aca⊠acaâacaâ¢acaâ acaâ acaâacaË I Saraav, K Pandey, M Sharma, S Singh, P Dutta - 2016 - academia.eduhttps://www.academia.edu/download/94032635/j.meegid.2016.07.00420221110-1-56hyo2.pdf Predicting promiscuous antigenic T cell epitopes of Mycobacterium tuberculosis mymA operon proteins binding to MHC Class I and Class II molecules I Saraav, K Pandey , M Sharma , S Singh , P Dutta - Infection, Genetics and , 2016 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1567134816302829 Quantification of HIV-1-specific T-cell responses at the mucosal cervicovaginal surface. DP wOOLEY, P KT, T RJ, P CC, B MA - Aids, 2000 - search.proquest.comhttps://search.proquest.com/openview/67df1d0818c025701edfd260f85c5c2c/1?pq-origsite=gscholar&cbl=32744N-(tert-Butoxycarbonyl)-L-valine Methyl Ester
CAS:Formula:C11H21NO4Purity:>95.0%(T)(HPLC)Color and Shape:Colorless to Light yellow to Light orange clear liquidMolecular weight:231.29H-TLSDPVFVR-OH
Peptide H-TLSDPVFVR-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-TLSDPVFVR-OH include the following: Purification and characterization of a chimeric Cry1F ÎŽ-endotoxin expressed in transgenic cotton plants Y Gao, KJ Fencil, X Xu, DA Schwedler - Journal of agricultural , 2006 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/jf0523869SNRPD2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SNRPD2 antibody, catalog no. 70R-4666Purity:Min. 95%Chymotrypsin
CAS:Chymotrypsin (Chymotrypsin A) is a serine protease produced by the pancreas that cleaves protein chains on the carboxyl side of aromatic amino acids.Purity:98%Color and Shape:SolidFLJ40504 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of FLJ40504 antibody, catalog no. 70R-4263Purity:Min. 95%FAM62B Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of FAM62B antibody, catalog no. 70R-6901Purity:Min. 95%Carcinine ditrifluoroacetate Acetate
Carcinine ditrifluoroacetate Acetate (β-Alanylhistamine dihydrochloride) is an H3 receptor antagonist.Formula:C14H20F6N4O7Purity:98.18%Color and Shape:SolidMolecular weight:470.32MAX Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of MAX antibody, catalog no. 70R-8413Purity:Min. 95%H-SCSSCPLSKILLARL-OH
Peptide H-SCSSCPLSKILLARL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-SCSSCPLSKILLARL-OH include the following: The generation and characterization of LMP2-specific CTLs for use as adoptive transfer from patients with relapsed EBV-positive Hodgkin disease CM Bollard , KCM Straathof , MH Huls - Journal of , 2004 - journals.lww.comhttps://journals.lww.com/immunotherapy-journal/fulltext/2004/07000/The_Generation_and_Characterization_of.00008.aspxIDH1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of IDH1 antibody, catalog no. 70R-2452Purity:Min. 95%FBN33428
CAS:FBN33428, also referred to as Fmoc-Phe-Lys(Boc)-PAB, is a hydrolyzable linker utilized in the synthesis of antibody-drug conjugates (ADCs). This compound facilitates the creation of hydrolyzable prodrugs, enhancing the targeted delivery of anticancer drugs to metastatic cells.Formula:C42H48N4O7Color and Shape:SolidMolecular weight:720.87CK1 α 1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CSNK1A1 antibody, catalog no. 70R-3672Purity:Min. 95%TAT-GluA2 3Y acetate(1404188-93-7 free base)
TAT-GluA2 3Y acetate is an inhibitor of AMPA receptor endocytosis.Systemic administration of Tat-GluA2(3Y) during the induction phase of d-amphetamine blockedFormula:C115H185N43O29Purity:99.43%Color and Shape:SolidMolecular weight:2634.02DL-2-(4-Hydroxyphenyl)glycine
CAS:Formula:C8H9NO3Purity:>95.0%(T)(HPLC)Color and Shape:White to Light yellow powder to crystalMolecular weight:167.16CMVpp65 - 93 (FTSQYRIQGKLEYRH)
Custom research peptide; min purity 95%. For different specs please use the Peptide Quote ToolMolecular weight:1,927.2 g/mol[(pF)Phe4]Nociceptin(1-13)NH2
CAS:Potent, selective OP4 agonist; pKi=10.68, pEC50=9.80. >8000x selectivity vs other opioid receptors; long-lasting in vivo effects.Formula:C61H99FN22O15Purity:98%Color and Shape:SolidMolecular weight:1399.6Somatostatin-28 (1-14)
Catalogue peptide; min. 95% purityFormula:C61H105N23O21SMolecular weight:1,528.72 g/molEsrp2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of Esrp2 antibody, catalog no. 70R-8539Purity:Min. 95%SLC13A3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SLC13A3 antibody, catalog no. 70R-1904Purity:Min. 95%H-GWYTSVITIELSNIKE-OH
Peptide H-GWYTSVITIELSNIKE-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-GWYTSVITIELSNIKE-OH include the following: Impact of formulation and particle size on stability and immunogenicity of oil-in-water emulsion adjuvants V Iyer, C Cayatte, B Guzman - Human vaccines & , 2015 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/21645515.2015.1046660 Inferior immunogenicity and efficacy of respiratory syncytial virus fusion protein-based subunit vaccine candidates in aged versus young mice C Cayatte, A Snell Bennett, GM Rajani , L Hostetler - PLoS , 2017 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0188708SOD1 (147-153) human
The SOD1 homodimer forms a β-barrel and contains an intramolecular disulphide bond and a binuclear Cu/Zn site in each subunit. This Cu/Zn site holds a copper and zinc ion and is responsible for catalysing the disproportionation of ROS, namely superoxide to hydrogen peroxide and dioxygen. In binding to copper and zinc ions, SOD1 is one of three superoxide dismutases responsible for destroying free superoxide radicals.The clinical relevance of SOD1 is related to its function in regulating ROS in the mitochondria of cells. Most notably, SOD1 is a crucial enzyme involved in ROS release during oxidative stress by ischemia-reperfusion injury, specifically in the myocardium as part of ischemic heart disease. During ischemia reperfusion, ROS release substantially contribute to the cell damage and death via a direct effect on the cell as well as via apoptotic signals. SOD1 is known to have a capacity to limit the detrimental effects of ROS. As such, SOD1 is important for its cardioprotective effects.Molecular weight:656.4 g/molHMGB4 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of HMGB4 antibody, catalog no. 70R-8414Purity:Min. 95%HAVCR2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of HAVCR2 antibody, catalog no. 70R-7244Purity:Min. 95%ZDHHC17 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ZDHHC17 antibody, catalog no. 70R-1832Purity:Min. 95%DBCO Agarose
DBCO-agarose is a 6% crosslinked agarose resin that is activated with DBCO functional groups for covalent capturing azide-tagged biomolecules utilizing Cu-free click conditions.Activation level: 10-20 µmol DBCO groups per mL resinBead size: 50-150 µmSupport: 6% Cross-linked agarosePurity:Min. 95%RPSA Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of RPSA antibody, catalog no. 70R-6040Purity:Min. 95%H-IGRNLLTQIGCTLNF-OH
Peptide H-IGRNLLTQIGCTLNF-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-IGRNLLTQIGCTLNF-OH include the following: The inhibition of HIV-1 protease by interface peptides HJ Schramm, A Billich, E Jaeger, KP Rucknagel - Biochemical and , 1993 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006291X83718632Murine CMV pp 89 (168-176)
CAS:Custom research peptide; min purity 95%. For different specs please use the Peptide Quote ToolFormula:C53H74N12O13SMolecular weight:1,119.32 g/molH-HLNILSTLWKYR-NH2
Peptide H-HLNILSTLWKYR-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-HLNILSTLWKYR-NH2 include the following: Targeted delivery of Tet1 peptide functionalized polymersomes to the rat cochlear nerve Y Zhang, W Zhang, AH Johnston - International journal , 2012 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.2147/IJN.S28185 Applications of Nanoparticles in Alzheimer's Disease Y Liu, Y Shen - Journal of Alzheimer's Disease, 2023 - content.iospress.comhttps://content.iospress.com/articles/journal-of-alzheimers-disease/jad230098 Tet1 peptide and zinc (II)-adenine multifunctional module functionalized polycations as efficient siRNA carriers for Parkinson's disease W Liu, C Ma, J Cao, H Zhou, T Guo - Journal of Controlled Release, 2024 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168365924000579 A means for targeting therapeutics to peripheral nervous system neurons with axonal damage T Federici, JK Liu , Q Teng, J Yang, NM Boulis - Neurosurgery, 2007 - journals.lww.comhttps://journals.lww.com/neurosurgery/fulltext/2007/05000/Bovine_Pericardium_for_Dural_Grafts__Clinical.15.aspx Non-viral carriers for nucleic acids delivery: Fundamentals and current applications S Shtykalova , D Deviatkin, S Freund, A Egorova - Life, 2023 - mdpi.comhttps://www.mdpi.com/2075-1729/13/4/903 "ÅCascaded Rocket"Â Nanosystems with Spatiotemporal Separation for Triple-Synergistic Therapy of Alzheimer's Disease R Liu , J Yang, X Qiu, W Ji, J Shen, Y Li - Advanced , 2022 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/adhm.202101748 Poly-Lactide/Poly-Lactide-co-Glycolide-Based Delivery System for Bioactive Compounds against Microbes R Kumar , D Jha , AK Panda - Pharmaceuticals from Microbes: The , 2019 - Springerhttps://link.springer.com/chapter/10.1007/978-3-030-01881-8_3 Diagnostic and therapeutic potential of tetanus toxin-derivatives in neurological diseases R Kassa, V Monterroso, LL David - Journal of Molecular , 2013 - Springerhttps://link.springer.com/article/10.1007/s12031-013-0065-x Development of peptide targeted PLGA-PEGylated nanoparticles loading licochalcone-A for ocular inflammation R Galindo, E Sanchez-Lopez, MJ Gomara, M Espina - Pharmaceutics, 2022 - mdpi.comhttps://www.mdpi.com/1999-4923/14/2/285 Development of surface-engineered PLGA nanoparticulate-delivery system of Tet1-conjugated nattokinase enzyme for inhibition of Abeta40 plaques in Alzheimer's PC Bhatt, A Verma , FA Al-Abbasi , F Anwar - International journal , 2017 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.2147/IJN.S144545 Systemic delivery of BACE1 siRNA through neuron-targeted nanocomplexes for treatment of Alzheimer's disease P Wang, X Zheng, Q Guo, P Yang, X Pang - Journal of controlled , 2018 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168365918302190 Therapeutic and diagnostic applications of nanocomposites in the treatment Alzheimer's disease studies M Pathak , R Singhal - Biointerface Research in Applied , 2022 - biointerfaceresearch.comhttps://biointerfaceresearch.com/wp-content/uploads/2021/04/20695837121.940960.pdf Polymeric nanoparticles properties and brain delivery L Ribovski , NM Hamelmann , JMJ Paulusse - Pharmaceutics, 2021 - mdpi.comhttps://www.mdpi.com/1999-4923/13/12/2045 Surface functionalization of PLGA nanoparticles to increase transport across the BBB for Alzheimer's disease L Del Amo, A Cano , M Ettcheto, EB Souto , M Espina - Applied sciences, 2021 - mdpi.comhttps://www.mdpi.com/2076-3417/11/9/4305 Polymeric nanoparticles as a vehicle for delivery of antioxidants in the brain: Potential application in neurodegenerative diseases JM Rabanel , G Djiokeng-Paka - Biomedical Application , 2017 - taylorfrancis.comhttps://www.taylorfrancis.com/chapters/edit/10.1201/9781315152363-12/polymeric-nanoparticles-vehicle-delivery-antioxidants-brain-jean-michel-rabanel-ghislain-djiokeng-paka-charles-ramassamy Nucleic-acid based Structures as Smart Nanotools in Neurotherapeutics JAV da Silva - 2016 - repositorio-aberto.up.pthttps://repositorio-aberto.up.pt/bitstream/10216/94251/2/157485.pdf Epigallocatechin-3-gallate (EGCG)-stabilized selenium nanoparticles coated with Tet-1 peptide to reduce amyloid-beta aggregation and cytotoxicity J Zhang, X Zhou, Q Yu, L Yang, D Sun - applied materials & , 2014 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/am501341u Conjugation, prodrug, and co-administration strategies in support of nanotechnologies to improve the therapeutic efficacy of phytochemicals in the central nervous G Rassu , M Sorrenti, L Catenacci, B Pavan , L Ferraro - Pharmaceutics, 2023 - mdpi.comhttps://www.mdpi.com/1999-4923/15/6/1578 Rational design of siRNA-based delivery systems for effective treatment of brain diseases D Lu, Y Sun, Y Luan, W He - Pharmaceutical Science Advances, 2024 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S2773216924000072 Tetanus toxin fragment C: structure, drug discovery research and production C Bayart , A Mularoni, N Hemmani , S Kerachni, J Jose - Pharmaceuticals, 2022 - mdpi.comhttps://www.mdpi.com/1424-8247/15/6/756 Overcoming barriers in non-viral gene delivery for neurological applications A Tasset, A Bellamkonda, W Wang , I Pyatnitskiy - Nanoscale, 2022 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2022/nr/d1nr06939j Curcumin loaded-PLGA nanoparticles conjugated with Tet-1 peptide for potential use in Alzheimer's disease A Mathew, T Fukuda, Y Nagaoka, T Hasumura - PLoS one, 2012 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0032616Tamapin
Tamapin, a venom peptide isolated from the Indian red scorpion (Mesobuthus tamulus) [1], selectively targets and blocks small-conductance Ca(2+)-activated KFormula:C146H238N44O41S6Purity:98%Color and Shape:SolidMolecular weight:3458.11H-YVYIAELLAHK^-OH
Peptide H-YVYIAELLAHK^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-YVYIAELLAHK^-OH include the following: Multidimensional protein identification technology-selected reaction monitoring improving detection and quantification for protein biomarker studies C Krisp, MJ McKay , DA Wolters , MP Molloy - Analytical chemistry, 2012 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/ac2028485 Proteomic profiling of exudates from diabetic foot ulcers and acute wounds using mass spectrometry C Krisp - 2022 - figshare.mq.edu.auhttps://figshare.mq.edu.au/ndownloader/files/34526789CEF7, Influenza Virus NP (380-388)
CAS:HLA-B*08 restricted influenza virus nucleoprotein epitope.Formula:C55H84N16O14Purity:98%Color and Shape:SolidMolecular weight:1193.35H-FSVYWAQADR-OH
Peptide H-FSVYWAQADR-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-FSVYWAQADR-OH include the following: Enhanced macrophage pannexin 1 expression and hemichannel activation exacerbates lethal experimental sepsis W Chen, S Zhu, Y Wang, J Li, X Qiang, X Zhao - Scientific Reports, 2019 - nature.comhttps://www.nature.com/articles/s41598-018-37232-z Role of pannexin 1 in Clostridium perfringens beta-toxin-caused cell death S Seike, M Takehara, K Kobayashi - Biochimica et Biophysica , 2016 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0005273616303303 Neurons respond directly to mechanical deformation with pannexin-mediated ATP release and autostimulation of P2X7 receptors J Xia, JC Lim, W Lu , JM Beckel - The Journal of , 2012 - Wiley Online Libraryhttps://physoc.onlinelibrary.wiley.com/doi/abs/10.1113/jphysiol.2012.227983 Suppression of presynaptic glutamate release by postsynaptic metabotropic NMDA receptor signalling to pannexin-1 J Bialecki, A Werner, NL Weilinger - Journal of , 2020 - Soc Neurosciencehttps://www.jneurosci.org/content/40/4/729.abstract Pannexin-1 modulates short-term synaptic plasticity by facilitating endocannabinoid transport J Bialecki - 2017 - prism.ucalgary.cahttps://prism.ucalgary.ca/server/api/core/bitstreams/8667bc92-7df1-4389-82d5-dba4f836a4e8/content The opening of connexin 43 hemichannels alters hippocampal astrocyte function and neuronal survival in prenatally LPS-exposed adult offspring CE Chavez, JE Oyarzacaºn, BC Avenda - Frontiers in cellular , 2019 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fncel.2019.00460/full Pannexin-1-Dependent Long-Term Depression at the CA3-CA1 Synapse AC Werner - 2021 - prism.ucalgary.cahttps://prism.ucalgary.ca/server/api/core/bitstreams/916681f4-2e8c-4552-ba95-3ab45d9772d6/contentDTNB Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of DTNB antibody, catalog no. 70R-3432Purity:Min. 95%Z-Gly-Pro-AMC
CAS:Z-Gly-Pro-AMC is a substrate molecule that mimics the natural substrate of dipeptidyl peptidase IV (DPP-IV) and is used in the study of plant physiology. It has been shown to inhibit DPP-IV activity by binding to the enzyme’s active site, preventing it from cleaving biologically active peptides. This drug also has an antidiabetic effect, which may be due to its ability to inhibit α-amylase activity. Z-Gly-Pro-AMC also has been shown to increase locomotor activity and reduce body weight in rats with metabolic disorders. Z-Gly-Pro-AMC inhibits serine proteases, such as trypsin, chymotrypsin, elastase, and cathepsin G, which are involved in tumor progression.Formula:C25H25N3O6Purity:Min. 98%Color and Shape:White PowderMolecular weight:463.48 g/molNeuromedin U8 (Porcine)
CAS:Neuromedin U8 (Porcine) is a peptide that binds to the receptor for Neuromedins. It has been shown to inhibit cell proliferation and induce apoptosis in some cancer cells. Neuromedin U8 has also been shown to have a protective effect on the bowel by inhibiting inflammatory bowel disease. The peptide is also known to be active on other physiological functions and metabolic disorders, such as amide metabolism and hypertrophy, which are due to its conformational properties.Formula:C54H78N16O10Purity:Min. 95%Molecular weight:1,111.32 g/molH-SFLLRN-OH
Thrombin Receptor Activator Peptide 6 (TRAP-6), also called Selective Protease-Activated Receptor 1 (PAR-1) Agonist, is an hexapeptide fragment of the thrombin receptor (residues 42-47). TRAP-6 has been shown to selectively activate PAR1 and thus induce platelet aggregation (EC50 = 0.8 μM). Its usefulness has therefore been demonstrated in cardiovascular study models and in hematology. Biologically, TRAP-6 is the N-terminal fragment of the thrombin receptor resulting from its cleavage by thrombin. This peptide therefore offers a cost-effective solution for the study of in-vitro cardiovascular models. What is PAR-1 ? Proteinase-activated receptor 1 (PAR1), also known as coagulation factor II (thrombin) receptor, is a G protein-coupled receptor and is involved in the regulation of thrombotic response. It is highly expressed in platelets and endothelial cells Other Applications ? Therefore, this peptide was used to activate platelets in vitro but it also demonstrated a protective action on astrocytes, which is associated with hypoglycemia. Thus, some research has focused on the use of TRAP-6 peptide to study the pathways that regulate hypoglycemia. Others have also been interested in TRAP-6 because of its stimulating action on certain transcription regulators, notably the yes-associated protein (YAP).ZNF300 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF300 antibody, catalog no. 70R-8220Purity:Min. 95%H-ELVVDFLSYK-OH
Peptide H-ELVVDFLSYK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-ELVVDFLSYK-OH include the following: Biochemical Pathways in Apoptosis D Nijhawan - 2005 - utswmed-ir.tdl.orghttps://utswmed-ir.tdl.org/bitstream/2152.5/336/3/nijhawandeepak.pdfN-Formyl-Met-Ala-Ser
CAS:N-Formyl-Met-Ala-Ser, a peptide, activates neutrophils via formyl peptide receptors.Formula:C12H21N3O6SPurity:98%Color and Shape:SolidMolecular weight:335.38H-VELGGGPGA-OH
Peptide H-VELGGGPGA-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-VELGGGPGA-OH include the following: Proinsulin-Specific, HLA-DQ8, and HLA-DQ8-Transdimer-Restricted CD4+ T Cells Infiltrate Islets in Type 1 Diabetes V Pathiraja, JP Kuehlich, PD Campbell - Diabetes, 2015 - Am Diabetes Assochttps://diabetesjournals.org/diabetes/article-abstract/64/1/172/34679 Induced pluripotent stem cell macrophages present antigen to proinsulin-specific T cell receptors from donor-matched islet-infiltrating T cells in type 1 diabetes K Joshi , C Elso, A Motazedian , T Labonne - Diabetologia, 2019 - Springerhttps://link.springer.com/article/10.1007/s00125-019-04988-6TRIM34 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of TRIM34 antibody, catalog no. 70R-8052Purity:Min. 95%Nα-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-glutamine
CAS:Formula:C20H20N2O5Purity:>98.0%(HPLC)Color and Shape:White to Almost white powder to crystalMolecular weight:368.39H-AISPRTLNAW-OH
Peptide H-AISPRTLNAW-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-AISPRTLNAW-OH include the following: Positioning of APOBEC3G/F Mutational Hotspots in the Human Immunodeficiency Virus Genome Favors Reduced Recognition by CD8+ T Cells M Monajemi, CF Woodworth, K Zipperlen, M Gallant - PLoS , 2014 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0093428 Novel role of APOBEC3G/F enzymes in adaptive immunity M Monajemi - 2012 - research.library.mun.cahttps://research.library.mun.ca/11065/ Schistosoma mansoni Soluble Egg Antigens Enhance T Cell Responses to a Newly Identified HIV-1 Gag H-2b Epitope CT Bui, LM Shollenberger , Y Paterson - Clinical and Vaccine , 2015 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/cvi.00514-14 Characterization of a monoclonal anti-capsid antibody that cross-reacts with three major primate lentivirus lineages BE Sanders-Beer, M Eschricht, J Seifried, VM Hirsch - Virology, 2012 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0042682211005228 Definition of a New HLA B* 52-Restricted Rev CTL Epitope Targeted by an HIV-1-Infected Controller B El Kenz, KG Schmidt, VK Ogungbemi-Alt - Viruses, 2023 - mdpi.comhttps://www.mdpi.com/1999-4915/15/2/567H-HHIYLGAVNYIY-OH
CAS:Peptide H-HHIYLGAVNYIY-OH (Met-12 Peptide) is a Research Peptide with significant interest as a small peptide Fas receptor agonist which as been used study inflammation responses. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-HHIYLGAVNYIY-OH include the following: Protective effect of Met12, a small peptide inhibitor of Fas, on the retinal pigment epithelium and photoreceptor after sodium iodate injury J Xiao, J Yao, L Jia, C Lin - Ophthalmology & Visual , 2017 - tvst.arvojournals.orghttps://tvst.arvojournals.org/article.aspx?articleid=2614664 HMGB1 release triggered by the interaction of live retinal cells and uveitogenic T cells is Fas/FasL activation-dependent G Jiang, Y Wang, J Yun , AR Hajrasouliha - Journal of , 2015 - Springerhttps://link.springer.com/article/10.1186/s12974-015-0389-2Formula:C71H99N17O17Molecular weight:1,462.65 g/molH-GLNDILEAQKIELHE-OH
Peptide H-GLNDILEAQKIELHE-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-GLNDILEAQKIELHE-OH include the following: A multifaceted hit-finding approach reveals novel LC3 family ligands M Steffek , E Helgason , N Popovych , L Rouge - Biochemistry, 2022 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.biochem.1c00682GOLGA5 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of GOLGA5 antibody, catalog no. 70R-6969Purity:Min. 95%EHD4 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of EHD4 antibody, catalog no. 70R-2680Purity:Min. 95%LL-37 scrambled peptide acetate
LL-37 scrambled peptide acetate is a scrambled peptide of LL-37 and is often used as a negative control for LL-37 peptide.Color and Shape:SolidH-YGNGVWIGR-OH
Peptide H-YGNGVWIGR-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-YGNGVWIGR-OH include the following: Identification of single amino acid substitutions (SAAS) in neuraminidase from influenza a virus (H1N1) via mass spectrometry analysis coupled with de novo peptide Q Peng, Z Wang, D Wu, X Li, X Liu- in Mass Spectrometry, 2016 - Wiley Online Libraryhttps://analyticalsciencejournals.onlinelibrary.wiley.com/doi/abs/10.1002/rcm.7650Somatostatin (Human, Ovine, Porcine, Rat, Mouse)
CAS:Somatostatin is a peptide hormone that has been found to inhibit pituitary growth hormone release as well as endocrine, pancreatic and GI secretions. It is widely expressed throughout the body for example in the gastrointestinal (GI) tract, hypothalamus, pancreas and the central nervous system. In the central nervous system somatostatin plays a role in neurotransmission modification and it has also demonstrated to be effective against a number of cancers such as squamous carcinoma. This product contains disulfide bonds between Cys3-Cys14 and is available as a 0.5mg vial.Formula:C76H10N18O19S2Purity:Min. 95%Molecular weight:1,637.9 g/molH-IYDSTTFR-OH
Peptide H-IYDSTTFR-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-IYDSTTFR-OH include the following: Protein expression and functional relevance of efflux and uptake drug transporters at the blood-brain barrier of human brain and glioblastoma X Bao , J Wu, Y Xie , S Kim - Clinical , 2020 - Wiley Online Libraryhttps://ascpt.onlinelibrary.wiley.com/doi/abs/10.1002/cpt.1710VDAC2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of VDAC2 antibody, catalog no. 70R-5053Purity:Min. 95%Calmin Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CLMN antibody, catalog no. 70R-7043Purity:Min. 95%Spaglumic acid acetate
Spaglumic acid acetate (Isospaglumic acid acetate) is a neuropeptide found in millimolar concentrations in brain.Formula:C13H20N2O10Purity:99.49%Color and Shape:SolidMolecular weight:364.31N-(4-methylbenzoyl)glycine
CAS:Formula:C10H11NO3Purity:98%Color and Shape:SolidMolecular weight:193.19923999999997LPPR2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of LPPR2 antibody, catalog no. 70R-7178Purity:Min. 95%H-GGGGRGDY-OH
Peptide H-GGGGRGDY-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-GGGGRGDY-OH include the following: The enhancement of chondrogenesis of ATDC5 cells in RGD-immobilized microcavitary alginate hydrogels Y Yao, L Zeng, Y Huang - Journal of Biomaterials , 2016 - journals.sagepub.comhttps://journals.sagepub.com/doi/abs/10.1177/0885328216640397 The effect of immobilized RGD peptide in macroporous alginate scaffolds on TGFbeta1-induced chondrogenesis of human mesenchymal stem cells T Re'em , O Tsur-Gang, S Cohen - Biomaterials, 2010 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0142961210006435 Gelatin-hyaluronic acid hydrogels with tuned stiffness to counterbalance cellular forces and promote cell differentiation S Poveda-Reyes, V Moulisova - Macromolecular , 2016 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/mabi.201500469 Rapid end-group modification of polysaccharides for biomaterial applications in regenerative medicine S Bondalapati, E Ruvinov, O Kryukov - Macromolecular , 2014 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/marc.201400354 The effect of RGD conjugation on mechanotransduction by chondrocytes in alginate under static compression NG Genes , LJ Bonassar - Orthopaedic Research Society, 2005 - ors.orghttps://www.ors.org/transactions/51/0344.pdf Culture of chondrocytes in RGD-alginate: effects on mechanical and biosynthetic properties NG Genes , JA Rowley , DJ Mooney , LJ Bonassar - Trans Orthop Res Soc, 2000 - ors.orghttps://www.ors.org/transactions/46/0201.pdf Chondrocyte Adhesion to RGD-bonded Alginate: Effect on Mechanotransduction and Matrix Metabolism: a Dissertation NG Genes - 2003 - repository.escholarship.umassmed https://repository.escholarship.umassmed.edu/handle/20.500.14038/32267 THE EFFECT OF SUBSTRATE STIFFNESS ON CHONDROCYTES ADHESION TO RGD-ALGINATE N Genes , L Bonassar - TRANSACTIONS OF THE ANNUAL MEETING , 2002 - ors.orghttps://www.ors.org/transactions/48/0265.pdf Chondroinductive/chondroconductive peptides and their-functionalized biomaterials for cartilage tissue engineering M Zhu, W Zhong, W Cao, Q Zhang, G Wu - Bioactive materials, 2022 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S2452199X21003364 The effect of immobilized RGD peptide in alginate scaffolds on cardiac tissue engineering M Shachar, O Tsur-Gang, T Dvir , J Leor , S Cohen - Acta biomaterialia, 2011 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1742706110003545 Fabrication and optimization of alginate hydrogel constructs for use in 3D neural cell culture JP Frampton , MR Hynd, ML Shuler - Biomedical materials, 2011 - iopscience.iop.orghttps://iopscience.iop.org/article/10.1088/1748-6041/6/1/015002/meta Biomaterials to spatially regulate cell fate JA Rowley , Z Sun, D Goldman - Advanced Materials, 2002 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/1521-4095(20020618)14:12%3C886::AID-ADMA886%3E3.0.CO;2-I Alginate type and RGD density control myoblast phenotype JA Rowley , DJ Mooney - Research: An Official Journal of The , 2002 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/jbm.1287 Controlling myoblast phenotype with RGD-modified alginate matrices JA Rowley - 2001 - search.proquest.comhttps://search.proquest.com/openview/265e5a5d1ea1057043e83280c3e4b0f6/1?pq-origsite=gscholar&cbl=18750&diss=y High-throughput physically based approach for mammalian cell encapsulation J Yu , PC Wu, CH Huang, CY Yang - Applied Physics , 2013 - pubs.aip.orghttps://pubs.aip.org/aip/apl/article/103/15/153704/25209 Three-dimensional hydrogel cell culture systems for modeling neural tissue J Frampton - 2009 - search.proquest.comhttps://search.proquest.com/openview/930caa15e2a5ffa200599a4e3134e11a/1?pq-origsite=gscholar&cbl=18750 3D Encapsulation and tethering of functionally engineered extracellular vesicles to hydrogels CC Huang , M Kang , S Shirazi, Y Lu, LF Cooper - Acta biomaterialia, 2021 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1742706121001781 Fabrication of three-dimensional hydrogel scaffolds for modeling shunt failure by tissue obstruction in hydrocephalus C Harris , K Pearson, K Hadley, S Zhu, S Browd - Fluids and Barriers of , 2015 - Springerhttps://link.springer.com/article/10.1186/s12987-015-0023-9 A hydrogel material for plastic and reconstructive applications injected into the subcutaneous space of a sheep C Halberstadt, C Austin, J Rowley , C Culberson - Tissue , 2002 - liebertpub.comhttps://www.liebertpub.com/doi/abs/10.1089/107632702753725067 Reduced cell attachment to poly(2-hydroxyethyl methacrylate)-coated ventricular catheters in vitro BW Hanak , CY Hsieh , W Donaldson - Research Part B , 2018 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/jbm.b.33915 In vivo characterization of a porous hydrogel material for use as a tissue bulking agent A Loebsack, K Greene, S Wyatt - Research: An Official , 2001 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/1097-4636(20011215)57:4%3C575::AID-JBM1204%3E3.0.CO;2-92-Amino-3-(5-methyl-1H-indol-3-yl)propanoic acid
CAS:Formula:C12H14N2O2Purity:98%Color and Shape:SolidMolecular weight:218.2518H-GFPSVLR^-OH
Peptide H-GFPSVLR^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-GFPSVLR^-OH include the following: Development of immuno-affinity mass spectrometry assays for the detection and quantification of viral antigens and antibodies D Dara - 2022 - era.library.ualberta.cahttps://era.library.ualberta.ca/items/dc616fa0-5a0f-4bb4-b427-45ee71ab769e Determination of the concentration range for 267 proteins from 21 lots of commercial human plasma using highly multiplexed multiple reaction monitoring mass C Gaither, R Popp, Y Mohammed, CH Borchers - Analyst, 2020 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2020/an/c9an01893j Mohammed,., & Borchers, CH (2020) C Gaither, R Popp - Determination of the concentration - scholarlypublications https://scholarlypublications.universiteitleiden.nl/access/item%3A3464256/downloadH-Gly-Pro-pNA•hydrochloride
CAS:H-Gly-Pro-pNA is an antidiabetic drug that inhibits the activity of dipeptidyl peptidase IV (DPP IV), a family of enzymes that catalyses the cleavage of the amino acid sequence of proline and arginine. The inhibitory effect on DPP IV by H-Gly-Pro-pNA was demonstrated using magnetic resonance spectroscopy, chromatographic assays, and electrospray ionization mass spectrometry. H-Gly-Pro-pNA also has hydrophobic properties and can interact with other drugs that are lipophilic. In vitro assays have been used to determine the inhibition activity of H-Gly-Pro-pNA against various proteins involved in diabetes mellitus, including aminopeptidases, carboxypeptidases and endopeptidases.Formula:C13H16N4O4•HClPurity:Min. 95%Color and Shape:White PowderMolecular weight:328.75 g/molN-Hydroxysuccinimide
CAS:Formula:C4H5NO3Purity:>98.0%(T)Color and Shape:White to Almost white powder to crystalMolecular weight:115.09WDR66 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of WDR66 antibody, catalog no. 70R-3677Purity:Min. 95%Biot-EAIYAAPFAKKK-OH
Peptide Biot-EAIYAAPFAKKK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Biot-EAIYAAPFAKKK-OH include the following: Catalytic specificity of protein-tyrosine kinases is critical for selective signalling Z Songyang, KL Carraway III, MJ Eck, SC Harrison - Nature, 1995 - nature.comhttps://www.nature.com/articles/373536a0 An ultrapotent and selective cyclic peptide inhibitor of human beta-factor XIIa in a cyclotide scaffold W Liu, SJ de Veer , YH Huang , T Sengoku - Journal of the , 2021 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/jacs.1c07574 Use of peptide biosensors for monitoring activity of kinases in chronic myelogenous leukemia TY Yang - 2014 - search.proquest.comhttps://search.proquest.com/openview/fe0978004046d5492d91ca4e0eda14bb/1?pq-origsite=gscholar&cbl=18750 In vitro selection of RNA binding peptides TT Takahashi - 2005 - thesis.library.caltech.eduhttps://thesis.library.caltech.edu/2099/ Development of peptidase resistant reporters for intracellular enzymatic activity S Yang - 2012 - cdr.lib.unc.eduhttps://cdr.lib.unc.edu/concern/dissertations/gf06g382q Inhibitor screening of protein kinases using MALDI-TOF MS combined with separation and enrichment of phosphopeptides by TiO 2 nanoparticle deposited capillary S Lu, Q Luo, X Li , J Wu, J Liu, S Xiong, YQ Feng - Analyst, 2010 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2010/an/c0an00339e Biarsenical-tetracysteine motif as a fluorescent tag for detection in capillary electrophoresis S Kottegoda, PC Aoto , CE Sims - Analytical chemistry, 2008 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/ac8003242 Activation of the c-Abl tyrosine kinase in the stress response to DMA-damaging agents S Kharbanda, R Ren, P Pandey , TD Shafman - Nature, 1995 - nature.comhttps://www.nature.com/articles/376785a0 Abl Protein Tyrosine Kinase (Abl) S Goff - ulab360.comhttp://www.ulab360.com/files/prod/manuals/201301/17/427806001.pdf Peptide Based Biosensors And Mass Spectrometric Methods To Measure The Activation Of Tyrosine Kinases RJ Schuster - 2016 - search.proquest.comhttps://search.proquest.com/openview/8403eb56042490bd2e438c6b1b19eb00/1?pq-origsite=gscholar&cbl=18750 Cysteine-rich peptides: Hyperstable scaffolds for protein engineering R Gonzalez-Castro, MA Gomez-Lim - ChemBioChem, 2021 - Wiley Online Libraryhttps://chemistry-europe.onlinelibrary.wiley.com/doi/abs/10.1002/cbic.202000634 Development of tools to study protein phosphorylation and nucleotidylation Q Yang - 2011 - search.proquest.comhttps://search.proquest.com/openview/6fa510952869ead678209e14566ee89f/1?pq-origsite=gscholar&cbl=18750 MALDI-TOF mass-spectrometry-based versatile method for the characterization of protein kinases N Kondo, SI Nishimura - Chemistry-A European Journal, 2009 - Wiley Online Libraryhttps://chemistry-europe.onlinelibrary.wiley.com/doi/abs/10.1002/chem.200801650 Development Of Kinase Catalyzed Biotinylation To Study Phosphoproteomics KACIB Senevirathne - 2013 - digitalcommons.wayne.eduhttps://digitalcommons.wayne.edu/oa_dissertations/698/ Oncogenic activation of c-Abl in non-small cell lung cancer cells lacking FUS1 expression: inhibition of c-Abl by the tumor suppressor gene product Fus1 J Lin, T Sun , L Ji , W Deng, J Roth , J Minna - Oncogene, 2007 - nature.comhttps://www.nature.com/articles/1210500 Generation of a dual-labeled fluorescence biosensor for Crk-II phosphorylation using solid-phase expressed protein ligation GJ Cotton, TW Muir - Chemistry & biology, 2000 - cell.comhttps://www.cell.com/ccbio/pdf/S1074-5521(00)00100-9.pdf Simple and sensitive method for determination of protein kinase activity based on surface charge change of peptide-modified gold nanoparticles as substrates F Yi, X Huang, J Ren - Analytical chemistry, 2018 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.analchem.7b04569 A peptide biosensor for detecting intracellular Abl kinase activity using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry EA Placzek, MP Plebanek, AM Lipchik , SR Kidd - Analytical , 2010 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0003269709006988 Biotinylated Phosphoproteins from Kinase-Catalyzed Biotinylation are Stable to Phosphatases: Implications for Phosphoproteomics C Senevirathne, MKH Pflum - ChemBioChem, 2013 - Wiley Online Libraryhttps://chemistry-europe.onlinelibrary.wiley.com/doi/abs/10.1002/cbic.201200626Ac-Asp-Glu • H2O
CAS:Ac-Asp-Glu • H2O is a water soluble molecule that belongs to the class of inhibitors. It has been shown to inhibit the polymerase chain reaction and is used as an analytical method for detecting DNA sequences. Ac-Asp-Glu • H2O induces neuronal death in the caudate putamen, thereby causing bowel disease, by inhibiting energy metabolism. This compound also inhibits the synthesis of proteins in the hippocampus, which leads to reduced locomotor activity and eosinophil cationic protein production. Ac-Asp-Glu • H2O is acidic and its concentration-time curve shows a bell shape. The half life of this compound is six hours.Formula:C11H16N2O8•H2OPurity:Min. 95%Molecular weight:322.28 g/molH-SVVAPATDGGLNLTSTFLR^-OH
Peptide H-SVVAPATDGGLNLTSTFLR^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-SVVAPATDGGLNLTSTFLR^-OH include the following: Site-and structure-specific characterization of the human urinary N-glycoproteome with site-determining and structure-diagnostic product ions Y Shen, K Xiao, Z Tian - Rapid Communications in Mass , 2021 - Wiley Online Libraryhttps://analyticalsciencejournals.onlinelibrary.wiley.com/doi/abs/10.1002/rcm.8952H-IQNILTEEPK^-OH
Peptide H-IQNILTEEPK^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-IQNILTEEPK^-OH include the following: Identification a novel clinical biomarker in early diagnosis of human non-small cell lung cancer Y Jin, Y Yang, Y Su, X Ye, W Liu, Q Yang, J Wang - Glycoconjugate , 2019 - Springerhttps://link.springer.com/article/10.1007/s10719-018-09853-z Multidimensional protein identification technology-selected reaction monitoring improving detection and quantification for protein biomarker studies C Krisp, MJ McKay , DA Wolters , MP Molloy - Analytical chemistry, 2012 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/ac2028485 Proteomic profiling of exudates from diabetic foot ulcers and acute wounds using mass spectrometry C Krisp - 2022 - figshare.mq.edu.auhttps://figshare.mq.edu.au/ndownloader/files/34526789 Targeted quantitation of CVD-linked plasma proteins for biomarker verification and validation AJ Percy , S Byrns, AG Chambers - Expert Review of , 2013 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1586/14789450.2013.856763 Protocol for standardizing high-to-moderate abundance protein biomarker assessments through an MRM-with-standard-peptides quantitative approach AJ Percy , J Yang, AG Chambers, Y Mohammed - , Analysis and Practical , 2016 - Springerhttps://link.springer.com/chapter/10.1007/978-3-319-41448-5_24 Multiplexed MRM-based quantitation of candidate cancer biomarker proteins in undepleted and non-enriched human plasma AJ Percy , AG Chambers, J Yang, CH Borchers - Proteomics, 2013 - Wiley Online Libraryhttps://analyticalsciencejournals.onlinelibrary.wiley.com/doi/abs/10.1002/pmic.201200316H-DYSNTHSTRYV-OH
Peptide H-DYSNTHSTRYV-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-DYSNTHSTRYV-OH include the following: Cytotoxic CD4+ T cells eliminate senescent cells by targeting cytomegalovirus antigen T Hasegawa, T Oka , HG Son , VS Oliver-GarcacaÂa, M Azin - Cell, 2023 - cell.comhttps://www.cell.com/cell/pdf/S0092-8674(23)00211-8.pdf Immunobiology of human cytomegalovirus: from bench to bedside T Crough, R Khanna - Clinical microbiology reviews, 2009 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/cmr.00034-08 Understanding human T-cell-mediated immunoregulation through herpesviruses SR Burrows , DJ Moss, R Khanna - Immunology and cell , 2011 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1038/icb.2010.136 What HIV has taught about the interactions between biology, culture, and other evolving systems S Mallal - On Human Nature, 2017 - Elsevierhttps://www.sciencedirect.com/science/article/pii/B9780124201903000466 Single-cell analysis shows that adipose tissue of persons with both HIV and diabetes is enriched for clonal, cytotoxic, and CMV-specific CD4+ T cells S Leary , M Mashayekhi , JD Simmons, CM Warren - Cell , 2021 - drive.google.comhttps://drive.google.com/file/d/1t3GdwbL55T9xkgN2asmUDomB7leWc_e1/view Is tandem autotransplantation necessary in myeloma? S Jagannath - Blood, The Journal of the American Society of , 2008 - ashpublications.orghttps://ashpublications.org/blood/article-abstract/111/4/1751/133204 Cross-recognition of human alloantigen by cytomegalovirus glycoprotein-specific CD4+ cytotoxic T lymphocytes: implications for graft-versus-host disease R Elkington, R Khanna - Blood, 2005 - ashpublications.orghttps://ashpublications.org/blood/article-abstract/105/3/1362/19642 Cross-reactive recognition of human and primate cytomegalovirus sequences by human CD4 cytotoxic T lymphocytes specific for glycoprotein B and H R Elkington, NH Shoukry , S Walker - European journal of , 2004 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.200425203 CD4+ T cells specific for glycoprotein B from cytomegalovirus exhibit extreme conservation of T-cell receptor usage between different individuals L Crompton, N Khan , R Khanna - Blood, The Journal , 2008 - ashpublications.orghttps://ashpublications.org/blood/article-abstract/111/4/2053/133352 Attack of the CD4 clones IJM ten Berge, RAW van Lier - Biochem Biophys Res Commun, 2001 - researchgate.nethttps://www.researchgate.net/profile/Rene-Van-Lier/publication/245982477_Attack_of_the_CD4_clones/links/5700022408aea6b77469b491/Attack-of-the-CD4-clones.pdf Cytomegalovirus (CMV) Epitope-Specific CD4+ T Cells Are Inflated in HIV+ CMV+ Subjects CO Abana , MA Pilkinton, S Gaudieri - The Journal of , 2017 - journals.aai.orghttps://journals.aai.org/jimmunol/article/199/9/3187/109888 Single-cell analysis shows that adipose tissue of persons with both HIV and diabetes is enriched for clonal, cytotoxic, and CMV-specific CD4+ T cells CN Wanjalla , WJ McDonnell , R Ram, A Chopra - Cell Reports , 2021 - cell.comhttps://www.cell.com/cell-reports-medicine/pdf/S2666-3791(21)00016-1.pdf CD4+ T cells expressing CX3CR1, GPR56, with variable CD57 are associated with cardiometabolic diseases in persons with HIV CN Wanjalla , CL Gabriel, H Fuseini, SS Bailin - Frontiers in , 2023 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2023.1099356/full HLA-DR and HLA-DP Restricted Epitopes from Human Cytomegalovirus Glycoprotein B Recognized by CD4+ T-Cell Clones from Chronically Infected Individuals C Ventura, H Bisceglia, Y Girerd-Chambaz - Journal of clinical , 2012 - Springerhttps://link.springer.com/article/10.1007/s10875-012-9732-x RAGs found"not guilty"Â: cleared by DNA evidence AG Tsai , MR Lieber - Blood, The Journal of the American , 2008 - ashpublications.orghttps://ashpublications.org/blood/article-abstract/111/4/1750/133194 Expanded cells in monoclonal TCR-alphabeta+/CD4+/NKa+/CD8âËâ/+dim T-LGL lymphocytosis recognize hCMV antigens A Rodriguez-Caballero - Blood, The Journal , 2008 - ashpublications.orghttps://ashpublications.org/blood/article-abstract/112/12/4609/24438 The cellular localisation of HCMV glycoprotein expression greatly influences the frequency and functional phenotype of specific CD4+ T-cell responses A Pachnio, J Zuo, GB Ryan , J Begum - Journal of immunology , 2015 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/mid/EMS64639/ The cellular localization of human cytomegalovirus glycoprotein expression greatly influences the frequency and functional phenotype of specific CD4+ T cell A Pachnio, J Zuo , GB Ryan , J Begum - The Journal of , 2015 - journals.aai.orghttps://journals.aai.org/jimmunol/article/195/8/3803/104854Ac-AQRSPQELFHEAAQQGC-NH2
Peptide Ac-AQRSPQELFHEAAQQGC-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Ac-AQRSPQELFHEAAQQGC-NH2 include the following: Slc12a8 is a nicotinamide mononucleotide transporter A Grozio , KF Mills, J Yoshino, S Bruzzone, G Sociali - Nature , 2019 - nature.comhttps://www.nature.com/articles/s42255-018-0009-4